DBV Technologies S.A. - American Depositary Shares (DBVT)
4.4400
0.00 (0.00%)
Dbv Technologies is a biopharmaceutical company focused on developing innovative therapies for patients with food allergies, particularly peanut allergies
Utilizing its proprietary Systemic Immunotherapy platform, the company aims to create treatments that help desensitize individuals to allergens, ultimately enhancing their quality of life and reducing the risk of severe allergic reactions. By leveraging advanced medical technology and a rigorous clinical development approach, Dbv Technologies strives to bring novel, breakthrough solutions to the field of immunotherapy for food allergies.

Châtillon, France, February 25, 2025
By DBV Technologies S.A. · Via GlobeNewswire · February 25, 2025

AMF Regulated InformationChâtillon, France, January 13, 2025
By DBV Technologies S.A. · Via GlobeNewswire · January 13, 2025

Châtillon, France, January 8th, 2025
By DBV Technologies S.A. · Via GlobeNewswire · January 8, 2025

Châtillon, France, December 11th, 2024
By DBV Technologies S.A. · Via GlobeNewswire · December 11, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
By DBV Technologies S.A. · Via GlobeNewswire · December 2, 2024

Châtillon, France, November 11, 2024
By DBV Technologies S.A. · Via GlobeNewswire · November 11, 2024

Châtillon, France, November 6, 2024
By DBV Technologies S.A. · Via GlobeNewswire · November 6, 2024
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Investors in healthcare and biotech sectors should keep an eye on several prominent companies making strides in innovation, clinical trials, and global expansion. Modular Medical (NASDAQMODD), Cardiol Therapeutics NASDAQ: CRDLNASDAQCRDL)(NASDAQ: DBVTNASDAQDBVT , and Virax Biolabs (NASDAQ: VRAXNASDAQ) are key players to watch in the ever-evolving medical landscape. Each company has announced significant developments in technology, trials, and product distribution, solidifying their positions in the market.
Via AB Newswire · October 23, 2024

Châtillon, France, October 22, 2024
By DBV Technologies S.A. · Via GlobeNewswire · October 22, 2024

Châtillon, France, October 18, 2024
By DBV Technologies S.A. · Via GlobeNewswire · October 18, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024
By DBV Technologies S.A. · Via GlobeNewswire · October 14, 2024

Châtillon, France, September 23, 2024
By DBV Technologies S.A. · Via GlobeNewswire · September 23, 2024

Châtillon, France, September 4, 2024
By DBV Technologies S.A. · Via GlobeNewswire · September 4, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
By DBV Technologies S.A. · Via GlobeNewswire · August 2, 2024

Châtillon, France, July 30, 2024
By DBV Technologies S.A. · Via GlobeNewswire · July 30, 2024

Châtillon, France, July 30, 2024
By DBV Technologies S.A. · Via GlobeNewswire · July 30, 2024

Châtillon, France, July 29, 2024
By DBV Technologies S.A. · Via GlobeNewswire · July 29, 2024

AMF Regulated InformationMontrouge, France, July 8, 2024
By DBV Technologies S.A. · Via GlobeNewswire · July 8, 2024

Châtillon, France, June 5, 2024
By DBV Technologies S.A. · Via GlobeNewswire · June 5, 2024

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024
By DBV Technologies S.A. · Via GlobeNewswire · June 4, 2024

Châtillon, France, May 31, 2024
By DBV Technologies S.A. · Via GlobeNewswire · May 31, 2024

Châtillon, France, May 30, 2024
By DBV Technologies S.A. · Via GlobeNewswire · May 30, 2024

Châtillon, France, May 17, 2024
By DBV Technologies S.A. · Via GlobeNewswire · May 17, 2024

Châtillon, France, May 16, 2024
By DBV Technologies S.A. · Via GlobeNewswire · May 16, 2024

Montrouge, France, May 9, 2024
By DBV Technologies S.A. · Via GlobeNewswire · May 9, 2024